OncoResponse
Signal active
Organization
Contact Information
Overview
OncoResponse is an immuno-oncology biotech company that is leveraging its proprietary human antibody platform to discover novel targets and identify fully human monoclonal antibodies as therapeutics for the treatment of cancers. It identifies genuine human antibodies to a variety of high-value targets linked with immunosuppressive myeloid biology. OncoResponse's antibody pipeline is expected to alleviate TME immunosuppression and boost immune activation, turning cold tumors hot.
About
Industries
Biotechnology, Health Care, Biopharma, Therapeutics, Oncology
Founded
2016
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
OncoResponse headquartered in United States, North America, operates in the Biotechnology, Health Care, Biopharma, Therapeutics, Oncology sector. The company focuses on Biotechnology and has secured $18.2B in funding across 140 round(s). With a team of 11-50 employees, OncoResponse is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - OncoResponse, raised $12.5M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
7
Investors
6
Lead Investors
0
Total Funding Amount
$130.1M
Details
6
OncoResponse has raised a total of $130.1M in funding over 6 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Late Stage Venture | 14.0M | ||
| 2017 | Early Stage Venture | 3.0M | ||
| 2016 | Early Stage Venture | 7.0M | ||
| 2016 | Early Stage Venture | 12.5M |
Investors
OncoResponse is funded by 51 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Canaan Partners | - | FUNDING ROUND - Canaan Partners | 12.5M |
| Rice University | - | FUNDING ROUND - Rice University | 12.5M |
| OncoResponse | - | FUNDING ROUND - OncoResponse | 12.5M |
| Alexandria Real Estate Equities | - | FUNDING ROUND - Alexandria Real Estate Equities | 12.5M |
Recent Activity
There is no recent news or activity for this profile.